GlassScriptPhysician profile
Fazel A Khan
NPI 1497732820
$1,905.12
in general payments reported to CMS, 2019-2025
8 companies · $323 in 2025
The $323 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $18.81 · 2021: $174 · 2022: $192 · 2023: $104 · 2024: $141 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.00 |
| Education | $112.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,349.89 | 2019-2025 | Mako, Insignia |
| Zimmer Biomet Holdings, INC. | $395.65 | 2020-2025 | Persona, Rosa |
| Ferring Pharmaceuticals INC. | $50.28 | 2021-2025 | Euflexxa |
| Medtronic, INC. | $35.47 | 2021 | |
| Boston Scientific Corporation | $32.71 | 2025 | Intracept |
| Carbofix Orthopedics INC | $26.13 | 2024 | |
| Kci USA, INC. | $12.84 | 2023 | Prevena |
| Illuminoss Medical, INC. | $2.15 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fazel Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.